Dare Bioscience, Inc. 8-K

What Happened Daré Bioscience, Inc. (DARE) filed a Form 8‑K on July 13, 2026 to furnish a corporate presentation dated July 13, 2026 (Exhibit 99.1). The company said it will use the presentation in meetings with securities market participants and others beginning July 13, 2026, and plans to make the slide deck available on its investor website under “Presentations, Events & Webcasts.” The filing also notes that information on the company website is not incorporated by reference into the 8‑K.

Key Details

• Exhibit furnished: 99.1 — Daré corporate presentation dated July 13, 2026.
• Use: Presentation will be used in meetings with investors and market participants starting July 13, 2026.
• Availability: Will be posted at https://ir.darebioscience.com → “Presentations, Events & Webcasts.”
• Regulatory note: Disclosure made under Item 7.01 (Regulation FD); website content is not incorporated by reference.

Why It Matters This filing signals Daré is distributing an updated corporate presentation to investors and market participants. While the 8‑K itself does not provide operational or financial data, the posted presentation is the likely source for any near‑term corporate updates (strategy, pipeline, or financial guidance). Retail investors should review the slide deck on the company’s investor site for any material information that could affect investment decisions.